Primary Treatment for Secondary Antiphospholipid Syndrome

Anticoagulation Strategy

The American College of Chest Physicians recommends warfarin as the cornerstone of treatment with a target INR of 2.5 (range 2.0-3.0) for both venous and most arterial thrombotic events 2
The American Heart Association suggests that moderate-intensity anticoagulation is strongly recommended over lower (INR <2) or higher (INR 3.0-5.0) ranges for most patients 2
For arterial thrombosis specifically, some guidelines suggest considering higher intensity anticoagulation (INR 3.0-4.0) may be appropriate, as recommended by the American College of Cardiology 3
Long-term (often indefinite) anticoagulation is required given the persistent nature of the antibodies and thrombotic risk, according to the American College of Rheumatology 5
Rivaroxaban is explicitly not recommended as it is associated with excess thrombotic events compared with warfarin, as stated by the American Heart Association 1
DOACs should be avoided in general for APS, and specifically in triple-positive patients due to increased risk of arterial thrombosis, especially stroke, as recommended by the American College of Cardiology 1, 3, 4, 5

Low-dose aspirin (75-100 mg daily) should be added to warfarin for patients with arterial thrombosis, as recommended by the American College of Cardiology 3, 4
For high-risk antibody profiles, aspirin is recommended even in asymptomatic patients for primary prevention, according to the American College of Rheumatology 3, 4

Triple-positive antibody status indicates highest risk for thrombotic events, as stated by the American College of Rheumatology 3, 4
Presence of lupus anticoagulant, even in isolation, confers higher risk, according to the American College of Cardiology 3, 4

During pregnancy, warfarin is contraindicated; switch to therapeutic-dose low molecular weight heparin plus low-dose aspirin throughout pregnancy and postpartum, as recommended by the American College of Obstetricians and Gynecologists 3, 4
For obstetric APS, use prophylactic-dose heparin plus aspirin, according to the American College of Obstetricians and Gynecologists 3, 4

Addition of hydroxychloroquine to standard anticoagulation is conditionally recommended for patients with primary APS and may be beneficial in secondary APS, as suggested by the American College of Rheumatology 3
Hydroxychloroquine should be continued during pregnancy to reduce pregnancy complications, according to the American College of Obstetricians and Gynecologists 4

Never use DOACs in triple-positive patients - this is associated with significantly increased thrombotic risk, as stated by the American Heart Association 1, 3, 5
Do not discontinue anticoagulation prematurely - antibodies typically persist and thrombotic risk remains elevated, according to the American College of Rheumatology 5
Avoid estrogen-containing contraceptives in women with positive antiphospholipid antibodies due to increased thrombosis risk, as recommended by the American College of Obstetricians and Gynecologists 4
Ensure proper overlap of parenteral anticoagulation when initiating warfarin therapy, according to the American College of Cardiology 5
Do not rely on a single positive antibody test - confirmation requires repeat testing at least 12 weeks apart, as stated by the American Heart Association 1, 3